Similar to the beneficial roles of insulin treatment on sensory deficits associated with DN, insulin treatment has been shown to protect against late-stage diabetes-induced motor neuropathy as well (Francis et al., 2011). The gene discussed is INS; the disease is liver dysplastic nodule.